RA CAPITAL MANAGEMENT, L.P. sold $146K of HOWL (indirect holdings)
RA CAPITAL MANAGEMENT, L.P. sold 416,911 indirectly-held shares of Werewolf Therapeutics, Inc. (HOWL) at $0.35 ($0.15M total) across 2 trades on 2026-06-17.
How this was made
The 30-second read
Why it matters
Traders may reassess near-term supply/demand dynamics and holder sentiment, but the disclosure alone is unlikely to change fundamentals.
Market read
A non-10b5-1 affiliate sale by a 10% owner is a modest sentiment/overhang datapoint for HOWL.
What to watch
The filing is indirect and does not specify the reason for sale; also, the $0.35 price level may reflect prevailing microcap trading conditions rather than a new valuation signal.
Background
SEC Form 4 insider transaction: RA Capital Management, L.P. (10% owner) reported an indirect open-market sale of Werewolf Therapeutics shares.
Ticker impact
RA Capital Management, a 10% owner, filed a Form 4 showing an indirect open-market sale of 416,911 HOWL shares at $0.35 on 2026-06-17.
Likely modest negative bias for HOWL shares around the filing window; magnitude depends on broader liquidity/float and whether other holders also sell.
Form 4 is primary-source and the transaction size (~$146k) is meaningful for a small-cap, but it is an indirect sale by an affiliate/owner and not a company fundamental update.
Market effects
Limited sector read-through; this is company-specific holder activity rather than industry/regulatory change.
None.
None.
Counterpoint
A single affiliate sale at a fixed low price may reflect diversification or liquidity needs rather than bearish fundamentals, especially if other holders remain steady.
Key entities
- issuerWerewolf Therapeutics, Inc.
Subject of the Form 4; ticker HOWL.
- 10% ownerRA Capital Management, L.P.
Reported indirect open-market sale of HOWL shares; no 10b5-1 plan indicated.
